ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Akoya BioSciences Inc

Akoya BioSciences Inc (AKYA)

4.49
0.38
( 9.25% )
Updated: 13:09:12

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.49
Bid
4.47
Ask
4.49
Volume
131,426
4.04 Day's Range 4.58
3.04 52 Week Range 8.80
Market Cap
Previous Close
4.11
Open
4.10
Last Trade
75
@
4.49
Last Trade Time
13:09:12
Financial Volume
$ 585,279
VWAP
4.4533
Average Volume (3m)
160,961
Shares Outstanding
49,140,731
Dividend Yield
-
PE Ratio
-3.49
Earnings Per Share (EPS)
-1.29
Revenue
96.63M
Net Profit
-63.32M

About Akoya BioSciences Inc

Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clini... Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Headquarters
Dover, Delaware, USA
Founded
1970
Akoya BioSciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker AKYA. The last closing price for Akoya BioSciences was $4.11. Over the last year, Akoya BioSciences shares have traded in a share price range of $ 3.04 to $ 8.80.

Akoya BioSciences currently has 49,140,731 shares outstanding. The market capitalization of Akoya BioSciences is $221.13 million. Akoya BioSciences has a price to earnings ratio (PE ratio) of -3.49.

AKYA Latest News

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

MARLBOROUGH, Mass. and FRANKFURT, Germany, May 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory...

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

MARLBOROUGH, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in...

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

MARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company...

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for...

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial...

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Q4 2023 revenue $26.5 million and FY 2023 revenue $96.6 millionGuiding FY 2024 revenue range $114.0-118.0 million and operating cash flow breakeven by YE 2024 MARLBOROUGH, Mass., March 04, 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4711.69154228864.024.583.8706904654.06765114CS
40.194.418604651164.34.583.721223943.9423848CS
12-1.05-18.95306859215.546.313.721609614.73874457CS
260.4310.59113300494.066.313.62231749094.85340255CS
52-2.15-32.37951807236.648.83.041894165.34074477CS
156-15.55-77.594810379220.0423.44263.041487909.86999713CS
260-21.51-82.73076923082628.943.0415040310.30451842CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SEZLSezzle Inc
$ 78.87
(76.29%)
570.33k
CPOPPop Culture Group Company Ltd
$ 2.9304
(72.38%)
70.91M
CCSIConcensus Cloud Solutions Inc
$ 18.425
(39.27%)
629.39k
GVVisionary Holdings Inc
$ 0.4002
(37.05%)
4.24M
MCRBSeres Therapeutics Inc
$ 1.025
(36.78%)
12.59M
EMKREMCORE Corporation
$ 1.125
(-61.21%)
4.4M
TIVCTivic Health Systems Inc
$ 0.5577
(-58.38%)
7.58M
CTMXCytomX Therapeutics Inc
$ 2.39
(-42.96%)
26.69M
RAPTRAPT Therapeutics Inc
$ 4.8025
(-39.82%)
3.14M
CDLXCardlytics Inc
$ 9.05
(-38.01%)
7M
GWAVGreenwave Technology Solutions Inc
$ 0.0717
(23.41%)
145.88M
SGDSafe and Green Development Corporation
$ 0.788
(27.10%)
90.21M
CPOPPop Culture Group Company Ltd
$ 2.9304
(72.38%)
70.91M
SQQQProShares UltraPro Short QQQ
$ 10.6698
(-0.65%)
64.42M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0412
(-1.44%)
57.52M

Discussion

View Full Feed
Iggy_Bot Iggy_Bot 11 seconds ago
Guess i spoke to soon...
GRPS
B402 B402 17 seconds ago
They are nuts, you are the weirdos and thats what the rest of us are stuck with now....

Something has to give, once dems sold their souls to the corps the greed people said was unsustainable could only lead to the inevitable out come of inequity run amuck.....Top that off with weirdne
Sheepdog Sheepdog 18 seconds ago
But you are ignoring the fact that it hasn't happened for thousands of years. That makes a given that it will never happen. And tomorrow I plan to invest in a new stock.....but that is impossible because I have never done it before. (all sarcasm)

Until the COURT says this is or isn't
VPLM
mikeymac mikeymac 36 seconds ago
This wasn't about your ability to find things. That is great. Go back and find out the dates that these things came to be. How long has the company had possession of these things. If we find out that they have a satellite delivery base that is in the mix, how much is it and why not mention it.
GGSM
Gnarlyman Gnarlyman 46 seconds ago
Everybody is bolting when the CEO is being transparent. Rarity in OTC, think I’ll just sit tight.
BLEG
t1215s t1215s 1 minute ago
GOGOOOOOOCOOP

GLTA-Ts
COOP
bull runs bull runs 1 minute ago
MSNBC panel in utter disbelief that more independent voters think Biden is a greater threat to democracy than Trump
DJT
glenn1919 glenn1919 1 minute ago
EAST.........................MULN..................................https://stockcharts.com/h-sc/ui?s=EAST&p=W&yr=1&mn=3&dy=0&id=p96837884856
https://stockcharts.com/h-sc/ui?s=MULN&p=W&yr=1&mn=3&dy=0&id=p96837884856
MULN
PRmaniac PRmaniac 1 minute ago
Warning! Limited Information

OTC Markets Group has confirmed that this company has limited disclosure or financial information publicly available, but meets a minimum requirement for public quoting under Rule 15c2-11. The Pink Limited Information tier may include companies that are
HPNN
manibiotech manibiotech 2 minutes ago
Didn’t he start Moonshot , RTT , so which GBM treatment did he bring in . You can send the message to the WH and see what happens .
NWBO
hopester hopester 2 minutes ago
Plug Up; Bloom Up; and FCEL makes a new 52 week low.
36.6 million shares heading for close to 50 million.
Market akers trying desparately to maintain an orderly market in the stock but the sellng is relentless.
Something is very wrong and whatever it is, will come out . this una
FCEL
Double DD Double DD 2 minutes ago
Drop the fins igpk,, get the ball rolling!! Igpk
IGPK
CantonG CantonG 2 minutes ago
Could be 21st. No set date.
MULN
price_and_volume price_and_volume 3 minutes ago
JK makes no mention of scanners in any filing.

He doesn’t mention any other keyword you might choose to look for in the last couple filings: passive, Texas, distributor, whatever.

“Nothing to report” is what he says.

No tweets either.

Ask y
VXIT
BlazingStocks BlazingStocks 3 minutes ago
$AGBA Article May 07, 2024

Triller and Nasdaq Listed AGBA Group: A Strategic Merger Revealing a $4 Billion Digital Powerhouse
https://okmagazine.com/p/triller-and-nasdaq-listed-agba-group-strategic-merger-revealing-digital-powerhouse/
AGBA
manibiotech manibiotech 3 minutes ago
Unless volume goes up a lot , these pops can’t sustain
NWBO
BlazingStocks BlazingStocks 3 minutes ago
$AGBA Article May 07, 2024

Triller and Nasdaq Listed AGBA Group: A Strategic Merger Revealing a $4 Billion Digital Powerhouse
https://okmagazine.com/p/triller-and-nasdaq-listed-agba-group-strategic-merger-revealing-digital-powerhouse/
AGBA
lighter than AIR lighter than AIR 3 minutes ago
No insiders selling…just Leonite the lender, who will hopefully be done soon
BMXI
Jetmek_03052 Jetmek_03052 4 minutes ago
Been over two hours now Jimmy Joe! I'm still waiting for that verifiable proof of Kramer being accused or convicted of "naked shorting" ANY stock....

Are you STILL searching for it? Because you stated:

If I'm not mistaken this family office has been caught naked shorti
DBMM
GBR GBR 4 minutes ago
Probably the best plug for Veritone from AWS that I have seen to date.

https://www.linkedin.com/feed/update/urn:li:activity:7194376323148963840/
VERI
TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 4 minutes ago
The only 1 starting to run is the CEO.
NICH
learningcurve2020 learningcurve2020 4 minutes ago
You'll notice the pumps are topping at a lower and lower share price. Likely a good reason for that. RS and a new trial.
NWBO
laraz5 laraz5 4 minutes ago
Paint yesterday just enough to get the PPS back over .03 but bid is locked in the .02s?

Sad ending to the never was?


IMO
XCRT

Your Recent History

Delayed Upgrade Clock